SCHEMBL12091895

SCHEMBL12091895

CC(C)(C)Cc1ccc([N+](=O)O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 5/20 0.54
▸ THRB P10828 2/20 0.46
▸ THRA P10827 1/20 0.46
▸ ALDH1A1 P00352 5/20 0.36
▸ HPGD P15428 1/20 0.36
▸ ESR2 Q92731 4/20 0.35
▸ BLM P54132 1/20 0.35
▸ TSHR P16473 1/20 0.34
▸ SLC6A2 P23975 2/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ LOXL2 Q9Y4K0 1/20 0.32
▸ HTR2A P28223 1/20 0.32
▸ SLC6A4 P31645 1/20 0.32
▸ HRH1 P35367 1/20 0.32
▸ HTR2B P41595 1/20 0.32
▸ CHRNA4 P43681 1/20 0.32
▸ SLC6A3 Q01959 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL75530 0.79 LOXL2 (0.55) ESR1THRBALDH1A1HPGDTSHR
SCHEMBL12713958 0.78 TSHR (0.37) ALDH1A1TSHRCYP2C19LOXL2
SCHEMBL6685103 0.76 ESR1 (0.74) ESR1THRBTHRAALDH1A1ESR2
SCHEMBL12786321 0.76 ALDH1A1 (0.40) ALDH1A1HPGDBLMTSHRCYP2C19
SCHEMBL12640633 0.76 ALDH1A1 (0.46) ALDH1A1TSHRCYP2C19SMN1; SMN2TAAR1
SCHEMBL18463857 0.75 CRHBP (0.36) ALDH1A1TSHRNPC1RAB9AMEN1
SCHEMBL15630260 0.73 TSHR (0.43) ALDH1A1TSHRCYP2C19LOXL2
SCHEMBL13981949 0.71 CES2 (0.42) ALDH1A1TSHRCYP2C19LOXL2
SCHEMBL13981951 0.71 HRH3 (0.52) ALDH1A1TSHRTAAR1
SCHEMBL358742 0.70 ESR1 (0.65) ESR1THRBTHRAESR2BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120226067-A1 PROCESSES FOR INTERMEDIATES FOR MACROCYCLIC COMPOUNDS MARSAULT ERIC (CA) 2012-09-06 — — US disclosed
US-20120226072-A1 PROCESSES FOR INTERMEDIATES FOR MACROCYCLIC COMPOUNDS MARSAULT ERIC (CA) 2012-09-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120226067-A1 PROCESSES FOR INTERMEDIATES FOR MACROCYCLIC COMPOUNDS MLNR, CHRM2, CCKAR ESR1 2190/4885THRB 567/4885THRA 454/4885
US-20120226072-A1 PROCESSES FOR INTERMEDIATES FOR MACROCYCLIC COMPOUNDS MLNR, CHRM2, CHRM1 ESR1 2200/4885THRB 670/4885THRA 506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback